Bridgeway Capital Management’s Ventyx Biosciences VTYX Stock Holding History

Bridgeway Capital Management’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-233,600	Closed	-$2.11M	–	1317
2025 Q4	$2.11M	Hold	233,600	–	–	0.04%	519
2025 Q3	$726K	Buy	233,600 +180,000	+336%	+$477K	0.02%	747
2025 Q2	$115K	Sell	53,600 -45,000	-46%	-$72.7K	﹤0.01%	1050
2025 Q1	$113K	Sell	98,600 -106,900	-52%	-$184K	﹤0.01%	1014
2024 Q4	$450K	Buy	205,500 +5,500	+3%	+$12.5K	0.01%	840
2024 Q3	$436K	Buy	+200,000	New	+$460K	0.01%	898
2024 Q1	–	Sell	-710,800	Closed	-$1.76M	–	1379
2023 Q4	$1.76M	Buy	+710,800	New	+$6.75M	0.04%	629

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bridgeway Capital Management's VTYX Position: Q1 2026 in Review

Bridgeway Capital Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 233,600 shares — an estimated $2.11M sold.

Bridgeway Capital Management first reported a position in VTYX in Q4 2023 and held it in 7 quarters. The position peaked at $2.11M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Bridgeway Capital Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Bridgeway Capital Management sold 233,600 Ventyx Biosciences shares in Q1 2026, an estimated $2.11M.
Bridgeway Capital Management first reported a position in Ventyx Biosciences in Q4 2023 and held it in 7 quarters.
Bridgeway Capital Management's Ventyx Biosciences position peaked at $2.11M in Q4 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.